Optogenetic technologies in translational cancer research

Area of Science:

• Biomedical Engineering
• Oncology
• Molecular Biology

Background:

• Gene and cell therapies show promise for cancer treatment but lack precise control.
• Optogenetics uses light-sensitive proteins to regulate gene and cell activity with high spatiotemporal precision.

Purpose of the Study:

• To review optogenetic approaches for cancer therapy.
• To discuss the clinical potential, challenges, and combinations of optogenetics with other cancer treatments.

Main Methods:

• Review of current optogenetic strategies in cancer research.
• Critical discussion of optogenetic integration with nanobodies, CAR-T cells, genome editors, and oncolytic viruses.
• Consideration of delivery methods (viral vectors, nanoparticles) and light activation.

Main Results:

• Optogenetics enables non-invasive, dose-controlled, tissue-confined modulation of tumor cell signaling and immune response.
• Combinations with therapeutic nanobodies, T-cell activation, CAR-T cells, genome editors, and oncolytic viruses show significant potential.
• Viral vectors and nanoparticles are viable for optogenetic payload delivery.

Conclusions:

• Optogenetics presents a novel, fast, reversible, and safe approach to enhance cancer immunotherapy.
• Overcoming challenges in clinical application is key to realizing optogenetics' full therapeutic potential.